ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
Source: SeekingAlpha
2026-02-04 13:32:33 ET
More on related tickers
- Trane Technologies: Upgrade To Buy On Cheaper Valuation And Better Fundamentals
- Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript
- Linde Q4 2025 Earnings Preview
- Genentech in up to $1.7B RNAi licensing deal with SanegeneBio
Read the full article on Seeking Alpha
For further details see:
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
Unicredito SpA ADR 2017
NASDAQ: UNCRY
UNCRY Trading
-2.83% G/L:
$39.04 Last:
145,480 Volume:
$39.1399 Open:
